Vittorio Arici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vittorio Arici has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Bozzani
Vascular and Endovascular Surgery Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
43 shared publications Franco Ragni
Vascular and Endovascular Surgery, Foundation I.R.C.C.S. Policlinico San Matteo, Pavia, Italy
16 shared publicationsAttilio Odero
IRCCS Policlinico San Matteo of Pavia Foundation
12 shared publicationsAngelo Argenteri
6 shared publicationsGiulia Ticozzelli
Anesthesia and Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, ITALY
6 shared publications- Antonio V. Sterpetti
Department of Surgery, University of Rome Sapienza, Italy
5 shared publications
Latest Publications
- 20 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (2) , 563
Letter regarding “Drug-coated balloons vs drug-eluting stents in the superficial femoral artery”
- 20 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (2) , 563
Letter regarding “Drug-coated balloons vs drug-eluting stents in the superficial femoral artery”
- Open Access
- 10 July 2026
- Published by Elsevier in Translational Oncology
- Vol. 71, 102882
Vasculopathy as a mechanical barrier to cancer spread: Clinical evidence and a rheology-based model in lung cancer and other solid tumors
- 10 July 2026
- Published by Elsevier in Translational Oncology
- Vol. 71, 102882
Open AccessVasculopathy as a mechanical barrier to cancer spread: Clinical evidence and a rheology-based model in lung cancer and other solid tumors
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1)
Candidemia Complicated by Mycotic Thrombus of the Femoral Artery in a Patient With Left Ventricular Assist Device
Background: Ventricular assist devices (VADs) are increasingly used as a bridge to transplantation or as destination therapy in heart failure patients. Fungal bloodstream infections, though less common than bacterial infections in VAD recipients, carry the highest mortality. Arterial involvement, including mycotic thrombus formation, is exceptionally rare and poses diagnostic and therapeutic challenges. We report the first documented case of candidemia complicated by femoral arterial mycotic thrombus in an LVAD recipient. Case Presentation: A 50‐year‐old man developed Candida albicans fungemia four months after undergoing LVAD implantation for severe dilated cardiomyopathy. Intravenous caspofungin was initiated due to potential azole–warfarin interactions. Blood cultures rapidly became negative, and multimodal imaging revealed no LVAD or endovascular involvement. On day 37 of ongoing antifungal therapy, ultrasound identified a subocclusive femoral artery thrombus at a prior cannulation site. Surgical thrombectomy confirmed C. albicans within the clot. Antifungal therapy continued, and the patient underwent successful emergency heart transplantation 15 days later. Discussion: Invasive fungal vascular infections may occur despite negative blood cultures and absence of detectable device involvement. Prior arterial trauma likely predisposed to localized fungal colonization. Management required careful risk assessment, prompt surgical intervention, and individualized antifungal therapy. Multidisciplinary collaboration among infectious disease specialists, radiologists, cardiologists, and cardiac surgeons was critical. Definitive source control through device explantation and transplantation was essential for curative intent. Device removal should be considered on a case‐by‐case basis, even when imaging shows no infectious foci, as prognosis without it may be poor. Fungal infection does not necessarily contraindicate transplantation, and early recognition combined with tailored therapy can optimize outcomes. Conclusions: Arterial Candida thrombus in LVAD recipients is rare but life‐threatening. High clinical suspicion, multimodal diagnostics, prompt surgical management, and individualized antifungal therapy are essential. Further studies are needed to define optimal antifungal strategies, surveillance, and transplant considerations for these high‐risk infections.
- 1 January 2026
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2026 (1)
Open AccessCandidemia Complicated by Mycotic Thrombus of the Femoral Artery in a Patient With Left Ventricular Assist Device
Background: Ventricular assist devices (VADs) are increasingly used as a bridge to transplantation or as destination therapy in heart failure patients. Fungal bloodstream infections, though less common than bacterial infections in VAD recipients, carry the highest mortality. Arterial involvement, including mycotic thrombus formation, is exceptionally rare and poses diagnostic and therapeutic challenges. We report the first documented case of candidemia complicated by femoral arterial mycotic thrombus in an LVAD recipient. Case Presentation: A 50‐year‐old man developed Candida albicans fungemia four months after undergoing LVAD implantation for severe dilated cardiomyopathy. Intravenous caspofungin was initiated due to potential azole–warfarin interactions. Blood cultures rapidly became negative, and multimodal imaging revealed no LVAD or endovascular involvement. On day 37 of ongoing antifungal therapy, ultrasound identified a subocclusive femoral artery thrombus at a prior cannulation site. Surgical thrombectomy confirmed C. albicans within the clot. Antifungal therapy continued, and the patient underwent successful emergency heart transplantation 15 days later. Discussion: Invasive fungal vascular infections may occur despite negative blood cultures and absence of detectable device involvement. Prior arterial trauma likely predisposed to localized fungal colonization. Management required careful risk assessment, prompt surgical intervention, and individualized antifungal therapy. Multidisciplinary collaboration among infectious disease specialists, radiologists, cardiologists, and cardiac surgeons was critical. Definitive source control through device explantation and transplantation was essential for curative intent. Device removal should be considered on a case‐by‐case basis, even when imaging shows no infectious foci, as prognosis without it may be poor. Fungal infection does not necessarily contraindicate transplantation, and early recognition combined with tailored therapy can optimize outcomes. Conclusions: Arterial Candida thrombus in LVAD recipients is rare but life‐threatening. High clinical suspicion, multimodal diagnostics, prompt surgical management, and individualized antifungal therapy are essential. Further studies are needed to define optimal antifungal strategies, surveillance, and transplant considerations for these high‐risk infections.
- 18 January 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (2) , 452-454
New candidates for screening of abdominal aortic aneurysm outside of current guidelines
- 18 January 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (2) , 452-454
New candidates for screening of abdominal aortic aneurysm outside of current guidelines
- 24 March 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (6) , 915
Telemedicine for Endovascular Aneurysm Repair Surveillance
- 24 March 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (6) , 915
Telemedicine for Endovascular Aneurysm Repair Surveillance
- 16 March 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (6) , 913
Re: Stenting of the Superficial Femoral Artery for Intermittent Claudication
- 16 March 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 65 (6) , 913
Re: Stenting of the Superficial Femoral Artery for Intermittent Claudication
- 3 February 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 73, e6-e7
Re: “Endothelitis in COVID-19-Positive Patients after Extremity Amputation for Acute Thrombotic Events”
- 3 February 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 73, e6-e7
Re: “Endothelitis in COVID-19-Positive Patients after Extremity Amputation for Acute Thrombotic Events”
- 1 February 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 71, 535.e17-535.e20
The Off-Label Use of a Leg Endoprosthesis for Internal Iliac Artery Aneurysm Treatment
- 1 February 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 71, 535.e17-535.e20
The Off-Label Use of a Leg Endoprosthesis for Internal Iliac Artery Aneurysm Treatment
- 1 February 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 71, 101-102
Endovascular Surgery during COVID-19 Virus Pandemic as a Valid Alternative to Open Surgery
- 1 February 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 71, 101-102
Endovascular Surgery during COVID-19 Virus Pandemic as a Valid Alternative to Open Surgery